Correlation Between Eliem Therapeutics and Edesa Biotech
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Edesa Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Edesa Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Edesa Biotech, you can compare the effects of market volatilities on Eliem Therapeutics and Edesa Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Edesa Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Edesa Biotech.
Diversification Opportunities for Eliem Therapeutics and Edesa Biotech
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Eliem and Edesa is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Edesa Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edesa Biotech and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Edesa Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edesa Biotech has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Edesa Biotech go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Edesa Biotech
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Edesa Biotech. In addition to that, Eliem Therapeutics is 1.39 times more volatile than Edesa Biotech. It trades about -0.11 of its total potential returns per unit of risk. Edesa Biotech is currently generating about -0.12 per unit of volatility. If you would invest 426.00 in Edesa Biotech on August 25, 2024 and sell it today you would lose (209.00) from holding Edesa Biotech or give up 49.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.21% |
| Values | Daily Returns |
Eliem Therapeutics vs. Edesa Biotech
Performance |
| Timeline |
| Eliem Therapeutics |
| Edesa Biotech |
Eliem Therapeutics and Edesa Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Edesa Biotech
The main advantage of trading using opposite Eliem Therapeutics and Edesa Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Edesa Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edesa Biotech will offset losses from the drop in Edesa Biotech's long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Edesa Biotech vs. Eliem Therapeutics | Edesa Biotech vs. HCW Biologics | Edesa Biotech vs. RenovoRx | Edesa Biotech vs. Scpharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |